SHELLIE HARDCASTLE: Open Payments
NPI 1033111901 · BOWLING GREEN, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,132 in 135 payments from 43 companies in 2025. Trend: 2023 $2,632 · 2024 $2,849 · 2025 $4,132
Food & beverage: $3,044Long term medical supply or device loan: $798Education: $290
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 16 | $959 |
| AstraZeneca Pharmaceuticals LP | 12 | $460 |
| Daiichi Sankyo Inc. | 6 | $250 |
| Janssen Biotech, Inc. | 8 | $248 |
| ABBVIE INC. | 5 | $196 |
| Gilead Sciences, Inc. | 7 | $189 |
| Merck Sharp & Dohme LLC | 9 | $160 |
| Regeneron Healthcare Solutions, Inc. | 6 | $156 |
| PFIZER INC. | 11 | $131 |
| BeOne Medicines USA, Inc. | 3 | $126 |
Products named: KISQALI, ENHERTU, Trodelvy, Venclexta, KEYTRUDA, DARZALEX, DATROWAY, LIBTAYO.
Industry payments across KY — which companies pay providers there.
